Latest Intravenous immunoglobulin Stories
The Science Magazine EurekaMag.com publishes articles in all areas of biological science.
A new study reports that a drug already approved by the Food and Drug Administration for use in patients undergoing a bone marrow transplant may also have promise for treating people who have a rare immune deficiency known as WHIM syndrome.
Hard-to-match kidney transplant candidates who receive a treatment designed to make their bodies more accepting of incompatible organs are twice as likely to survive eight years after transplant surgery as those who stay on dialysis for years awaiting compatible organs.
A new treatment for hard-to-match kidney transplant patients is providing dramatic survival benefits.
WASHINGTON, May 25, 2011 /PRNewswire-USNewswire/ -- The Immune Deficiency Foundation (IDF) applauds Representatives Kevin Brady (R-TX) and Doris Matsui (D-CA) and Senators John Kerry (D-MA) and Lamar Alexander (R-TN) for introducing H.R. 1845 and S. 960, both entitled the Medicare IVIG Access Act.
CINCINNATI, April 4, 2011 /PRNewswire/ -- CarePoint Partners (CarePoint) today announced at the National Home Infusion Association Annual Conference in Orlando, Florida that it has acquired Infusion Technologies, a provider of home infusion therapies including antibiotics, IVIG, nutrition, the associated nursing services and a variety of specialty injections, with locations in North Miami and Tampa.
KING OF PRUSSIA, Pa., March 21, 2011 /PRNewswire/ -- Data presented by CSL Behring today suggest that treatment with higher dose HizentraÂ® (IgPro 20) correlates with reduced risk of infection and missed school or work among patients with primary immunodeficiencies (PI).
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.